JP Patent

JP7562562B2 — パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ

Assigned to ハー・ルンドベック・アクチエゼルスカベット · Expires 2024-10-07 · 2y expired

What this patent protects

Patent listed against foscarbidopa.

Drugs covered by this patent

Patent Metadata

Patent number
JP7562562B2
Jurisdiction
JP
Classification
—
Expires
2024-10-07
Drug substance claim
No
Drug product claim
No
Assignee
ハー・ルンドベック・アクチエゼルスカベット
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.